MedPath
NMPA Approval

Methotrexate Injection

国药准字HJ20233146

March 24, 2023

Drug Information

甲氨蝶呤注射液

注射剂

0.50ml:25mg

化学药品

March 24, 2023

March 23, 2028

Company Information

Applicant Company

Theaterstraβe 6, 22880 Wedel, Germany

Manufacturing Company

Am Pharmapark, 06861 Dessau-Roβlau, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲氨蝶呤注射液 - NMPA 批准文号 | MedPath